HC
GILD icon

Hara Capital’s Gilead Sciences GILD Stock Holding History

Hara Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Hold
2,940
– – 0.2% 104
2026
Q1 		$410K Sell
2,940
-65
-2% -$9.1K 0.2% 100
2025
Q4 		$369K Hold
3,005
– – 0.21% 100
2025
Q3 		$334K Hold
3,005
– – 0.2% 97
2025
Q2 		$333K Hold
3,005
– – 0.21% 97
2025
Q1 		$337K Hold
3,005
– – 0.23% 97
2024
Q4 		$278K Hold
3,005
– – 0.18% 108
2024
Q3 		$252K Hold
3,005
– – 0.16% 109
2024
Q2 		$206K Sell
3,005
-10
-0.3% -$667 0.13% 128
2024
Q1 		$221K Hold
3,015
– – 0.13% 123
2023
Q4 		$244K Buy
+3,015
New +$235K 0.17% 110

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hara Capital's GILD Position: Q2 2026 in Review

Hara Capital held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,940 shares worth $371K. The position accounts for 0.2% of the portfolio, ranked #104.

Hara Capital first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $410K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hara Capital held 2,940 shares of Gilead Sciences worth $371K as of Q2 2026.
  • Hara Capital left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.2% of Hara Capital's portfolio in Q2 2026, its #104 holding.
  • Hara Capital first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Hara Capital's Gilead Sciences position peaked at $410K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.